These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11927017)

  • 1. Expression of thymidine phosphorylase in primary human renal cell carcinoma by ELISA method.
    Kinsui H; Ueda T; Suzuki H; Isaka S; Sekita N; Komiya A; Tobe T; Yamanishi T; Akakura K; Ichikawa T; Igarashi T; Ito H
    Jpn J Cancer Res; 2002 Mar; 93(3):340-5. PubMed ID: 11927017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma.
    Imazano Y; Takebayashi Y; Nishiyama K; Akiba S; Miyadera K; Yamada Y; Akiyama S; Ohi Y
    J Clin Oncol; 1997 Jul; 15(7):2570-8. PubMed ID: 9215827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High levels of thymidine phosphorylase as an independent prognostic factor in renal cell carcinoma.
    Takayama T; Mugiya S; Sugiyama T; Aoki T; Furuse H; Liu H; Hirano Y; Kai F; Ushiyama T; Ozono S
    Jpn J Clin Oncol; 2006 Sep; 36(9):564-9. PubMed ID: 16861722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of thymidine phosphorylase/platelet-derived endothelial cell growth factor activity in renal cell carcinoma.
    Mizutani Y; Wada H; Yoshida O; Fukushima M; Kawauchi A; Nakao M; Miki T
    Cancer; 2003 Aug; 98(4):730-6. PubMed ID: 12910516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase in renal cell carcinoma.
    Morita T; Matsuzaki A; Tokue A
    Oncology; 2003; 65(2):125-31. PubMed ID: 12931018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidine phosphorylase levels as a prognostic factor in renal cell carcinoma.
    Wada S; Yoshimura R; Naganuma T; Yoshida N; Narita K; Ikemoto S
    BJU Int; 2003 Jan; 91(1):105-8. PubMed ID: 12614261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymidine phosphorylase/platelet-derived endothelial cell growth factor (PD-ECGF) associated with prognosis in renal cell carcinoma.
    Suzuki K; Morita T; Hashimoto S; Tokue A
    Urol Res; 2001 Feb; 29(1):7-12. PubMed ID: 11310220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymidine phosphorylase activity in renal cell carcinoma: relationship between histological parameters and chemosensitivity to fluorouracil-related drugs.
    Hirano Y; Takayama T; Kageyama S; Ushiyama T; Suzuki K; Fujita K
    Urol Res; 2002 May; 30(2):112-5. PubMed ID: 12086015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomodulation of 5-fluorouracil by interferon-alpha in human renal carcinoma cells: relationship to the expression of thymidine phosphorylase.
    Morita T; Tokue A
    Cancer Chemother Pharmacol; 1999; 44(2):91-6. PubMed ID: 10412941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidine phosphorylase as a prognostic factor in renal cell carcinoma.
    Padrik P; Saar H
    Int Urol Nephrol; 2010 Jun; 42(2):295-8. PubMed ID: 19572207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ELISA level and immunohistochemical status for thymidine phosphorylase (TP) in invasive breast carcinoma.
    Kurosumi M; Sugamata N; Tabei T; Inoue K; Matsumoto H; Suemasu K; Higashi Y
    Anticancer Res; 2002; 22(1A):331-8. PubMed ID: 12017313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The correlation between thymidine phosphorylase activity of renal cancer cells and the chemosensitivity to 5-FU and 5'-DFUR].
    Hirano Y; Takayama T; Ushiyama T; Suzuki K; Fujita K
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1779-81. PubMed ID: 9757207
    [No Abstract]   [Full Text] [Related]  

  • 13. Significance of thymidine phosphorylase in HCC with chronic liver disease for long-term postoperative recurrence.
    Ezaki T; Ikegami T; Ishida T; Aimitsu S; Mori M; Fujihara M
    J Surg Oncol; 2003 Jul; 83(3):173-9; discussion 179. PubMed ID: 12827687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic analysis of angiogenic factors in localized renal cell carcinoma: the influence of neoadjuvant treatment.
    Kawata N; Yagasaki H; Yuge H; Nakanoya Y; Fujimura K; Sugimoto S; Hirakata H; Takimoto Y
    Int J Urol; 2001 Jun; 8(6):275-81. PubMed ID: 11389742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymidine phosphorylase activity in liver tissue and its correlation with multifocal occurrence of hepatocellular carcinomas.
    Ikeguchi M; Sakatani T; Ueda T; Hirooka Y; Kaibara N
    In Vivo; 2001; 15(4):265-70. PubMed ID: 11695216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with interferon gamma in renal cell carcinoma cell lines.
    Ikemoto S; Sugimura K; Yoshida N; Kuratsukuri K; Wada S; Nakatani T
    Anticancer Res; 2002; 22(6C):4023-7. PubMed ID: 12553027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of thymidine phosphorylase activity in liver tissue adjacent to hepatocellular carcinoma.
    Ezaki T; Ikegami T; Maeda T; Yamada T; Ishida T; Hashizume M; Maehara Y
    Int J Clin Oncol; 2005 Jun; 10(3):171-6. PubMed ID: 15990964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor Prognosis Associated with High Levels of Thymidine Phosphorylase and Thrombocytosis in Patients with Renal Cell Carcinoma.
    Huang X; Wang L; Chen Y; Zheng X; Wang X
    Urol Int; 2017; 98(2):162-168. PubMed ID: 27532673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy.
    Koukourakis MI; Giatromanolaki A; Fountzilas G; Sivridis E; Gatter KC; Harris AL
    Clin Cancer Res; 2000 Feb; 6(2):381-9. PubMed ID: 10690514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidine phosphorylase expression as a prognostic marker for predicting recurrence in primary superficial bladder cancer.
    Aoki S; Yamada Y; Nakamura K; Taki T; Tobiume M; Honda N
    Oncol Rep; 2006 Aug; 16(2):279-84. PubMed ID: 16820903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.